Genmab A/S GNMSF
546.00 USD -28.50 (-4.96%)
Nov 4, 2026, 10:02 AM EST
546.00 Day range 546.00
232.34 52-week range 581.00
- YTD
- +73.89%
- 1 year
- +92.86%
- Market cap
- 33.57B
- EPS (ttm)
- 12.66
- P/E ratio
- 43.13
- YTD return
- +73.89%
- 1-year return
- +92.86%
- Volume
- 1
- Avg volume
- 2.29K
- Open
- 546.00
- Previous close
- 574.50
- Day's range
- 546.00 – 546.00
- 52-week range
- 232.34 – 581.00
- Earnings date
- Nov 5, 2026
2Y +320.00 (+141.59%)
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 3.84.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 3.84 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 3.56 | 5.42 | +1.86 | +52.25% |
| May 7, 2026 | Mar 31, 2026 | 1.56 | 0.85 | -0.71 | -45.51% |
| Feb 17, 2026 | Dec 31, 2025 | 2.81 | 0.51 | -2.30 | -81.85% |
| Nov 6, 2025 | Sep 30, 2025 | 4.86 | 6.46 | +1.60 | +32.92% |
| Aug 7, 2025 | Jun 30, 2025 | 3.99 | 5.42 | +1.43 | +35.84% |
News
Genmab A/S (GMAB) Q1 2026 Earnings Call Transcript 
Genmab A/S (OTCMKTS:GNMSF) Stock Price Crosses Below 200 Day Moving Average – Here’s Why 
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript 
Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript 
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance 
Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript 
Genmab A/S (GMAB) Discusses 2025 R&D Progress, ASH Data Review, and Strategic Pipeline Additions Transcript 
Genmab A/S (GMAB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript 
Genmab A/S (GMAB) Presents at Jefferies London Healthcare Conference 2025 Transcript 
Genmab A/S (GMAB) Q3 2025 Earnings Call Transcript
Your note
Sign in to keep a note on GNMSF — it syncs with the Stock Master app.